Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014 |
Resumo: | This study was carried out to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers among adolescents aged between 10 and 16 years old, who are elementary school students in the city of Chapecó, Santa Catarina State, Brazil. The study involved a cross-sectional survey that included 418 volunteers, from March to July, 2008. Serology comprised HBsAg, anti-HBc, anti-HBs and anti-HCV. Tests were performed using automated Microparticle Enzyme Immunosorbant Assay (Abbott, AxSYM System, Wiesbaden, Germany). The prevalence of HBsAg was found to be 0.2% (95%CI: 0.0-1.3), and the prevalence of anti-HBc was found to be 1.4% (95%CI: 0.5-3.1). Regarding anti-HBs, 48.6% had titers greater than 10UI/L. None of the volunteers presented reactive results for anti-HCV. This study showed a low prevalence of HBV and HCV markers of infection and a great number of volunteers immunized against HBV. Finally this study shows the importance of proper health campaigns and policies in reducing those prevalences. |
id |
FIOCRUZ-5_899de258b631dd5edd6ed95f39852ce8 |
---|---|
oai_identifier_str |
oai:scielo:S0102-311X2011000400014 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern BrazilHepatitis BHepatitis CVaccinationSeroepidemiologic StudiesThis study was carried out to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers among adolescents aged between 10 and 16 years old, who are elementary school students in the city of Chapecó, Santa Catarina State, Brazil. The study involved a cross-sectional survey that included 418 volunteers, from March to July, 2008. Serology comprised HBsAg, anti-HBc, anti-HBs and anti-HCV. Tests were performed using automated Microparticle Enzyme Immunosorbant Assay (Abbott, AxSYM System, Wiesbaden, Germany). The prevalence of HBsAg was found to be 0.2% (95%CI: 0.0-1.3), and the prevalence of anti-HBc was found to be 1.4% (95%CI: 0.5-3.1). Regarding anti-HBs, 48.6% had titers greater than 10UI/L. None of the volunteers presented reactive results for anti-HCV. This study showed a low prevalence of HBV and HCV markers of infection and a great number of volunteers immunized against HBV. Finally this study shows the importance of proper health campaigns and policies in reducing those prevalences.Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz2011-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014Cadernos de Saúde Pública v.27 n.4 2011reponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZ10.1590/S0102-311X2011000400014info:eu-repo/semantics/openAccessScaraveli,Natália GazzoniPassos,Ana MariaVoigt,Andréia RoyerLivramento,Andréa doTonial,GabrielaTreitinger,AricioSpada,Celsoeng2011-05-09T00:00:00Zoai:scielo:S0102-311X2011000400014Revistahttp://cadernos.ensp.fiocruz.br/csp/https://old.scielo.br/oai/scielo-oai.phpcadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2011-05-09T00:00Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil |
title |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil |
spellingShingle |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil Scaraveli,Natália Gazzoni Hepatitis B Hepatitis C Vaccination Seroepidemiologic Studies |
title_short |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil |
title_full |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil |
title_fullStr |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil |
title_full_unstemmed |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil |
title_sort |
Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil |
author |
Scaraveli,Natália Gazzoni |
author_facet |
Scaraveli,Natália Gazzoni Passos,Ana Maria Voigt,Andréia Royer Livramento,Andréa do Tonial,Gabriela Treitinger,Aricio Spada,Celso |
author_role |
author |
author2 |
Passos,Ana Maria Voigt,Andréia Royer Livramento,Andréa do Tonial,Gabriela Treitinger,Aricio Spada,Celso |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Scaraveli,Natália Gazzoni Passos,Ana Maria Voigt,Andréia Royer Livramento,Andréa do Tonial,Gabriela Treitinger,Aricio Spada,Celso |
dc.subject.por.fl_str_mv |
Hepatitis B Hepatitis C Vaccination Seroepidemiologic Studies |
topic |
Hepatitis B Hepatitis C Vaccination Seroepidemiologic Studies |
description |
This study was carried out to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers among adolescents aged between 10 and 16 years old, who are elementary school students in the city of Chapecó, Santa Catarina State, Brazil. The study involved a cross-sectional survey that included 418 volunteers, from March to July, 2008. Serology comprised HBsAg, anti-HBc, anti-HBs and anti-HCV. Tests were performed using automated Microparticle Enzyme Immunosorbant Assay (Abbott, AxSYM System, Wiesbaden, Germany). The prevalence of HBsAg was found to be 0.2% (95%CI: 0.0-1.3), and the prevalence of anti-HBc was found to be 1.4% (95%CI: 0.5-3.1). Regarding anti-HBs, 48.6% had titers greater than 10UI/L. None of the volunteers presented reactive results for anti-HCV. This study showed a low prevalence of HBV and HCV markers of infection and a great number of volunteers immunized against HBV. Finally this study shows the importance of proper health campaigns and policies in reducing those prevalences. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0102-311X2011000400014 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
dc.source.none.fl_str_mv |
Cadernos de Saúde Pública v.27 n.4 2011 reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1754115731152175104 |